Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals During Pregnancy

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02213-16
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Early Experience of Dolutegravir Pharmacokinetics in Pregnancy

AIDS
Infectious DiseasesAllergyImmunology
2016English

Figure 1: FDA Approved Integrase Strand Transfer Inhibitors INSTIs: Raltegravir, Elvitegravir and Dolutegravir.

English

Antenatal Pharmacokinetics and Placental Transfer of N-Acetylcysteine in Chorioamnionitis for Fetal Neuroprotection

Journal of Pediatrics
Child HealthPediatricsPerinatology
2014English

Safety of Antiretrovirals in Pregnancy

Southern African Journal of HIV Medicine
Infectious Diseases
2009English

The Pharmacokinetics of Oral Indoramin During Pregnancy.

British Journal of Clinical Pharmacology
Pharmacology
1990English

Ethosuximide in Epileptic Women During Pregnancy and Lactation Period. Placental Transfer, Serum Concentrations in Nursed Infants and Clinical Status.

British Journal of Clinical Pharmacology
Pharmacology
1984English

Cardiovascular Programming During and After Diabetic Pregnancy: Role of Placental Dysfunction and IUGR

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Artemether-Lumefantrine Co-Administration With Antiretrovirals: Population Pharmacokinetics and Dosing Implications

British Journal of Clinical Pharmacology
Pharmacology
2015English

Improving Access to Antiretrovirals in China: Economic Analyses of Dolutegravir in HIV-1 Patients

Cost Effectiveness and Resource Allocation
Health Policy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy